Erythema Nodosum (EN)



Background

  • Panniculitis (inflam. of subcutaneous fat
  • Delayed hypersensitivity Rxn to a variety of antigens
  • Painful, erythematous nodules, lower legs
  • F:M = 6:1, 20-40 years old
  • Self-limiting or recurrent
  • Frequently assoc. systemic symptoms
ENlegs

Aetiology

  • Idiopathic (30-50% of cases)
  • Infections (˜30%):
    • Streptococcal pharyngitis (˜20-30%)
    • Tuberculosis (<5% in developed countries)
    • Yersinia, EBV, Mycoplasma, Histoplasma
  • Systemic diseases:
  • Medications:
    • Sulfonamides, oral contraceptives, penicillins (<5%)
  • Other:
    • Pregnancy (<5%)

Clinical

  • Clinical Dx
  • Nodules:
    • Tender, erythematous
    • 2-6 cm diameter, poorly demarcated
    • Evolve over 1-2 weeks into bruise
    • Resolve without ulceration/scarring
  • Systemic features (with or preceding nodules)
    • Fever, malaise
    • Arthralgia

Differential Dx

  • Cellulitis (common mimic; initially misdiagnosed in ˜25% of EN cases)
  • Cutaneous vasculitis (e.g. polyarteritis nodosa)
  • Lupus panniculitis
  • Nodular fat necrosis
  • Erythema induratum (tuberculous origin)
  • Superficial thrombophlebitis

Investigations

A targeted work-up is essential and includes:

  • Throat swab and ASO titre (Streptococcus)
  • Chest X-ray (Sarcoidosis, TB)
  • TB screening / Hx if suspected
  • FBC, CRP, ESR
  • Stool calprotectin ±colonoscopy (if IBD suspected)
  • Urinalysis (if systemic vasculitis suspected)
  • Β-HCG (if pregnancy is possible)
  • Biopsy (rarely) = septal panniculitis without vasculitis

Management

  • Supportive care: NSAIDs, rest, leg elevation, compression stockings
  • ID / treat the underlying cause if found
  • Self-limiting in most cases, resolving in 3-6 weeks

Prognosis

  • Typically resolves without complications
  • 30% of cases (underlying e.g. IBD/sarcoid)
  • Prognosis excellent is underlying condition treated



Content by Dr Samuel McGreal 05/06/2025. Last review Dr ÍOS 5/06/25.